Hi Everyone! I got an email a little while ago from Ashley at MediciGlobal regarding a Clinical Research Study. Please read the following message regarding the study and if interested give them a call. Thanks! :)

RE: Clinical Research Study Evaluating An Investigational Medication for Relapsing Forms of Multiple Sclerosis.

Medical researchers are enrolling people in a worldwide clinical research study for people with relapsing forms of multiple sclerosis (RMS). This study will assess the safety and effectiveness of an investigational study medication versus placebo (an inactive substance which contains no active medication) in people ages 18-55 years old with RMS. The investigational medication used in this study is called teriflunomide (ter-i-flün-o-mïde). It is derived from leflunomide (le-flü-no-mïde), also known as Arava®. Arava® is already approved in many countries for the treatment of rheumatoid arthritis, another autoimmune disease. The first step in determining eligibility for this study is to take the pre-screening questionnaire either online or on the phone. You will be asked a series of questions related to your health and be given additional information about study site locations. Visit http://www.blogger.com/www.tower3.msstudies.com or call 1-866-565-0245 today to learn more about the study and see if you may qualify.

So, if you or someone you love has MS and is looking for a different medication or an opportunity to try something new, give them a call. I personally don't know what the criteria to participate in this study is (with the exception of being 18-55 with RRMS) so it will be important for you to call if you are interested. If you do decide to take part in this study and you are a good candidate, please let me know. I would love to hear how it goes and what progress is being made.

I hope each of you are doing well. Take care!
~Jaime